Loading stock data…
$4.69-0.13 (-2.66%)
Decoy Therapeutics Inc.
Decoy Therapeutics Inc. in the Healthcare sector is trading at $4.69. Wall Street consensus targets $30.00 (1 analysts), implying a +539.4% move over the next 12 months. The stock is currently near its 52-week low of $4.61, remaining 83.0% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Decoy Therapeutics Inc. operates as a pre-clinical stage biotechnology company. It focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that leverage...